advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (13)
Showing records 1 to 13
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation53946 Apoptotic effects of topical antiglaucoma medications on conjunctival epithelium in glaucoma patients
Arici MK; Ozeç AV; Dursun A; Toker MI; Erdogan H
European Journal of Ophthalmology 2013; 0: 0
54040 Tear film status in glaucoma patients
Jandroković S; Suić SP; Kordić R; Kuzman T; Petricek I
Collegium Antropologicum 2013; 37: 137-140
53795 Evaluation of Ocular Surface Disease in Patients with Glaucoma
Mathews PM; Ramulu PY; Friedman DS; Utine CA; Akpek EK
Ophthalmology 2013; 120: 2241-2248
53856 An Effective Prodrug Strategy to Selectively Enhance Ocular Exposure of a Cannabinoid Receptor (CB1/2) Agonist
Mainolfi N; Powers J; Amin J; Long D; Lee W; McLaughlin ME; Jaffee B; Brain CT; Elliott J; Sivak JM
Journal of Medicinal Chemistry 2013; 0:
53739 Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension
Konstas AG; Quaranta L; Katsanos A; Riva I; Tsai JC; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Floriani I; Haidich AB
British Journal of Ophthalmology 2013; 97: 1510-1515
53875 Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
Day DG; Walters TR; Schwartz GF; Mundorf TK; Liu C; Schiffman RM; Bejanian M
British Journal of Ophthalmology 2013; 97: 989-993
53925 Novel Topical Ophthalmic Formulations for Management of Glaucoma
Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM
Pharmaceutical Research 2013; 30: 2818-2831
53587 Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study
Mastropasqua L; Agnifili L; Fasanella V; Curcio C; Ciabattoni C; Mastropasqua R; Toto L; Ciancaglini M
Acta Ophthalmologica 2013; 91: e397-e405
54013 Ophthalmic Delivery of Brinzolamide by Liquid Crystalline Nanoparticles: In Vitro and In Vivo Evaluation
Wu W; Li J; Wu L; Wang B; Wang Z; Xu Q; Xin H
AAPS PharmSciTech 2013; 14: 1063-1071
54020 Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids
Galbis-Estrada C; Pinazo-Durán MD; Cantú-Dibildox J; Marco-Ramírez C; Díaz-Llópis M; Benítez-Del-Castillo J
Clinical Interventions in Aging 2013; 8: 711-719
54050 Influence on ocular surface and intraocular pressure of switching from preservative-containing to preservative-free carteolol hydrochloride ophthalmic solution
Chikama T; Araie M; Nishida T
Nippon Ganka Gakkai Zasshi 2013; 117: 419-426
53532 Liposomal diltiazem HCl as ocular drug delivery system for glaucoma
Mokhtar Ibrahim M; Tawfique SA; Mahdy MM
Drug Development and Industrial Pharmacy 2014; 40: 765-773
53606 Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues
Ensign LM; Henning A; Schneider CS; Maisel K; Wang YY; Porosoff MD; Cone R; Hanes J
Molecular pharmaceutics 2013; 10: 2176-2182
